Literature DB >> 17558735

Correlation of malignant phenotypes of human tumour cell lines with augmented expression of Hsp72 protein measured by laser scanning cytometry.

T Hamamoto1, K Suzuki, S Kodama, H Sasaki, K Abe, T Hayashi, M Watanabe.   

Abstract

Augmented expression of members of the heat shock protein 70 (Hsp70) family are frequently observed in various human cancers. In this study, we examined applicability of laser scanning cytometer (LSC) to evaluate the level of Hsp72, which is the member constitutively expressed and significantly induced after heat shock, in human tumour cell lines. The relative nuclear content of Hsp72 measured by LSC correlated well with the relative intracellular content determined by Western blotting (R = 0.906). Furthermore, there was a close relationship between the relative nuclear content of Hsp72 measured by LSC and the colony-forming ability in soft agar, one of the malignant characteristics of tumour cells (R = 0.880). These results indicate that LSC measurement is useful for predicting the degree of malignancy of cancer cells, as it is reliable, faster than Western blotting and more objective and quantitative than visual measurements.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558735     DOI: 10.1080/02656730701302528

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  2 in total

1.  Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin.

Authors:  Vanniarajan Ayyasamy; Kjerstin M Owens; Mohamed Mokhtar Desouki; Ping Liang; Andrei Bakin; Kumarasamy Thangaraj; Donald J Buchsbaum; Albert F LoBuglio; Keshav K Singh
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

2.  High-Performance Near-Infrared Fluorescent Secondary Antibodies for Immunofluorescence.

Authors:  Cynthia L Schreiber; Dong-Hao Li; Bradley D Smith
Journal:  Anal Chem       Date:  2021-02-10       Impact factor: 6.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.